INTERPACE BIOSCIENCES, INC. Deferred Income Tax Expense (Benefit)
INTERPACE BIOSCIENCES, INC. (IDXGD) reported Deferred Income Tax Expense (Benefit) of -$21.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-30
- INTERPACE BIOSCIENCES, INC. deferred income tax expense (benefit) for the quarter ending 2015-12-31 was -$533.00K.
- INTERPACE BIOSCIENCES, INC. deferred income tax expense (benefit) for fiscal 2025 was -$21.25M.
- INTERPACE BIOSCIENCES, INC. deferred income tax expense (benefit) for fiscal 2021 was $38.00K, a 2.70% increase from fiscal 2020.
- INTERPACE BIOSCIENCES, INC. deferred income tax expense (benefit) for fiscal 2020 was $37.00K, a 105.56% increase from fiscal 2019.
- INTERPACE BIOSCIENCES, INC. deferred income tax expense (benefit) for fiscal 2019 was $18.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | -$21.25M 10-K · filed 2026-03-30 | |||
| 2021-12-31 | $38.00K 10-K · filed 2022-03-31 | |||
| 2020-12-31 | $37.00K 10-K · filed 2022-03-31 | |||
| 2019-12-31 | $18.00K 10-K · filed 2021-04-01 | |||
| 2015-12-31 | -$533.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$1.17M 10-K · filed 2017-03-31 | ||
| 2015-09-30 | -$634.00K 10-Q · filed 2016-11-17 | |||
| 2014-12-31 | -$5.04M 10-K · filed 2016-03-30 | |||
| 2013-12-31 | $0.00 10-K · filed 2015-03-05 | |||
| 2012-12-31 | -$62.00K 10-K · filed 2014-03-06 | |||
| 2011-12-31 | -$21.00K 10-K · filed 2013-03-15 | $0.00 10-K · filed 2012-03-09 | ||
| 2010-12-31 | $5.00K 10-K · filed 2012-03-09 |